Company page

Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd. (Ticker: GLMD) is a public company operating in the American market. The company has a market capitalization of approximately $4.24 million. Galmed focuses on developing innovative therapies for liver diseases and other metabolic disorders.

GLMD:NASDAQUpdated July 31, 2026
Galmed Pharmaceuticals Ltd. logo
Ticker
GLMD:NASDAQ
Asset type
Stock
Market cap
$5.1M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD